// App-Quantinova.ai

OA06 : Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions

Researchers

Presenter

  • Maya H Buch

Principal Investigators

  • Bernard Combe

  • Jose A Gomez-Puerta

  • Roberto Caporali

  • Jacques-Eric Gottenberg

  • Paul Van Hoek

  • Vijay Rajendran

  • Pieter-Jan Stiers

  • Katrien van Beneden

  • Daniel Aletaha

  • Gerd Burmester

  • Rene Westhovens

  • Yoshiya Tanaka

Medical Centers

  • Department of Rheumatology, CHU Montpellier and Montpellier University, Montpellier, France

  • Galapagos, Mechelen, Belgium

  • Department of Urology, Strasbourg University Hospital, Strasbourg, France

  • Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain

  • Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium

  • Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan

  • Division of Musculoskeletal & Dermatological Sciences, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Clinical Sciences and Community Health, University of Milan, Milan, Italy

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Department of OB/GYN, Division of Senology, Medical University of Vienna, Vienna, Austria

Locations

  • France

  • Japan

  • Belgium

  • United Kingdom

  • Italy

  • Spain

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved